|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.80 ILa | +0.73% |
|
-12.22% | -18.79% |
| 05-01 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 03-04 | InterCure Receives Noncompliance Notice From Nasdaq | MT |
Company Valuation: InterCure Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 440.5 | 932.3 | 550.5 | 211 | 271.8 | 176.9 |
| Change | - | 111.63% | -40.95% | -61.66% | 28.77% | -34.89% |
| Enterprise Value (EV) 1 | 407.6 | 844.6 | 572.9 | 305.4 | 404.5 | 313.3 |
| Change | - | 107.2% | -32.17% | -46.69% | 32.45% | -22.55% |
| P/E Ratio | -11.2x | 207x | 12.2x | -3.41x | -4.01x | -4.87x |
| PBR | 1.6x | 2.09x | 1.1x | 0.46x | 0.71x | 0.45x |
| PEG | - | -2x | 0x | 0x | -0.45x | 0.1x |
| Capitalization / Revenue | 6.77x | 4.24x | 1.42x | 0.59x | 1.14x | 0.65x |
| EV / Revenue | 6.27x | 3.84x | 1.47x | 0.86x | 1.69x | 1.16x |
| EV / EBITDA | 286x | 23.8x | 11.9x | 45.7x | -5.17x | -5.66x |
| EV / EBIT | -338x | 27.8x | 14x | -203x | -4.6x | -4.66x |
| EV / FCF | -33x | 116x | -12.3x | -5.23x | -13x | -8.37x |
| FCF Yield | -3.03% | 0.86% | -8.16% | -19.1% | -7.71% | -11.9% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.466 | 0.1 | 0.9882 | -1.36 | -1.48 | -0.6645 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 65.04 | 219.7 | 388.7 | 355.6 | 238.8 | 270.2 |
| EBITDA 1 | 1.425 | 35.53 | 48.34 | 6.681 | -78.22 | -55.34 |
| EBIT 1 | -1.205 | 30.41 | 40.85 | -1.503 | -87.89 | -67.24 |
| Net income 1 | -37.23 | 4.692 | 44.82 | -61.96 | -67.8 | -35.71 |
| Net Debt 1 | -32.88 | -87.64 | 22.37 | 94.35 | 132.8 | 136.3 |
| Reference price 2 | 16.351 | 20.720 | 12.080 | 4.631 | 5.938 | 3.236 |
| Nbr of stocks (in thousands) | 26,942 | 44,994 | 45,573 | 45,573 | 45,765 | 54,681 |
| Announcement Date | 3/31/21 A | 4/5/22 A | 3/31/23 A | 5/1/24 A | 5/1/25 A | 4/30/26 A |
1ILS in Million2ILS
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 48.16M | |
| 11.69x | - | - | - | 153M | |
| 13.22x | - | - | - | 115M | |
| -1.32x | 0.68x | 2.99x | - | 106M | |
| -2.01x | 1.12x | 6.1x | - | 98.88M | |
| Average | 5.39x | 0.90x | 4.54x | 104.08M | ||
| Weighted average by Cap. | 6.29x | 0.89x | 4.49x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- INCR Stock
- Valuation InterCure Ltd.
Select your edition
All financial news and data tailored to specific country editions
